Morepen Laboratories’ wholly owned subsidiary-- Dr. Morepen (DML) has received approval from Board of Directors for the formation of a new subsidiary company on February 19, 2025. The proposed entity will be named ‘Quick Med’ or any other name as approved by the Central Registration Centre, Ministry of Corporate Affairs (Proposed Company).
Upon incorporation, the proposed company will become a step-down subsidiary of Morepen Laboratories. The proposed new company will operate in the pharmaceutical sector, specializing in the 'Online Retail Pharmacy' business.
Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagnostics, Formulations and OTC products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: